Chevron Corporation
213.81USD
+4.0100 (+1.91%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $4.73▲ | $4.42 | 13 | 4 |
| Next quarter | $4.07▲ | $3.81 | 10 | 7 |
| Current year | $16.13▲ | $14.53 | 19 | 4 |
| Next year | $13.47▲ | $12.57 | 16 | 7 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $5.57 | $6.06 | +0.49 (+8.8%) |
| 2026-03-31 | $0.97 | $1.41 | +0.44 (+45.6%) |
| 2025-12-31 | $1.44 | $1.52 | +0.08 (+5.2%) |
| 2025-09-30 | $1.71 | $1.85 | +0.14 (+8.4%) |
445 ratings from 49 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BMO Capital | Maintained | Outperform | $210 $235 | Sep 3, 2026 |
| Piper Sandler | Maintained | Overweight | $207 $243 | Sep 3, 2026 |
| Wells Fargo | Maintained | Overweight | $226 $230 | Sep 3, 2026 |
| Morgan Stanley | Maintained | Overweight | $210 $218 | Aug 19, 2026 |
| Barclays | Maintained | Equal-Weight | $216 $208 | Aug 17, 2026 |
| TD Cowen | Maintained | Hold | $200 $205 | Aug 5, 2026 |
| Bernstein | Maintained | Market Perform | $204 $209 | Aug 3, 2026 |
| Barclays | Maintained | Equal-Weight | $213 $216 | Aug 3, 2026 |
| B of A Securities | Maintained | Buy | $210 $227 | Jul 28, 2026 |
| TD Cowen | Maintained | Hold | $197 $200 | Jul 22, 2026 |
| Wolfe Research | Upgraded from Peer Perform | Outperform | $210 | Jul 2, 2026 |
| Morgan Stanley | Maintained | Overweight | $214 $210 | Jun 29, 2026 |
| Mizuho | Maintained | Outperform | $225 $230 | May 27, 2026 |
| Barclays | Maintained | Equal-Weight | $192 $213 | May 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $212 $214 | May 22, 2026 |
| Bernstein | Maintained | Market Perform | $216 $204 | May 11, 2026 |
| RBC Capital | Reiterated | Outperform | $220 | May 5, 2026 |
| UBS | Maintained | Buy | $218 $220 | May 4, 2026 |
| Barclays | Maintained | Equal-Weight | $180 $192 | May 4, 2026 |
| Scotiabank | Maintained | Sector Perform | $168 $187 | Apr 22, 2026 |
| BNP Paribas | Upgraded from Neutral | Outperform | $174 | Apr 17, 2026 |
| RBC Capital | Maintained | Outperform | $200 $220 | Apr 13, 2026 |
| Wells Fargo | Maintained | Overweight | $204 $222 | Apr 9, 2026 |
| Citigroup | Maintained | Buy | $210 $235 | Apr 2, 2026 |
| Morgan Stanley | Maintained | Overweight | $174 $212 | Mar 27, 2026 |
152 filings from 26 insiders · 19 buy / 10 sell over 6m
Officers and directors of CVX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HEWSON MARILLYN ADirector | OtherPhantom Stock | 213 | $201.86 | $43k | Aug 28, 2026 |
| WARNER CYNTHIA JDirector | OtherPhantom Stock | 19 | $201.86 | $4k | Aug 28, 2026 |
| PATE ROBERT HEWITTOfficer | Sellindirect | 2.5k | $205.11 | $507k | Aug 18, 2026 |
| MOYO DAMBISA FDirector | Gift | 350 | — | — | Aug 17, 2026 |
| WALZ ANDREW BENJAMINOfficer | Exercise | 16.8k | $88.20 | $2.05M | Aug 17, 2026 |
| WALZ ANDREW BENJAMINOfficer | Sell | 16.8k | $201.06 | $3.38M | Aug 17, 2026 |
| WIRTH MICHAEL KChief Executive Officer | Sell | 317.1k | $200.44 | $63.57M | Aug 14, 2026 |
| WIRTH MICHAEL KChief Executive Officer | Exercise | 317.1k | $88.20 | $27.97M | Aug 14, 2026 |
| GUSTAVSON JEFF B.Officer | Exercise | 14.0k | $113.01 | $1.66M | Aug 11, 2026 |
| GUSTAVSON JEFF B.Officer | Sell | 14.0k | $194.95 | $2.74M | Aug 11, 2026 |
| WIRTH MICHAEL KChief Executive Officer | Sell | 5.5k | $187.00 | $1.04M | Aug 5, 2026 |
| HESS JOHN B JR.Director | Sell | 810.7k | $192.75 | $157.37M | Aug 3, 2026 |
| HESS JOHN B JR.Director | Exercise | 709.4k | $48.51 | $50.35M | Aug 3, 2026 |
| HESS JOHN B JR.Director | Grant | 1.3k | — | — | May 27, 2026 |
| HEWSON MARILLYN ADirector | Grant | 1.3k | — | — | May 27, 2026 |
| HORTON THOMAS WDirector | Grant | 1.3k | — | — | May 27, 2026 |
| HERNANDEZ ENRIQUEJRDirector | Grant | 1.3k | — | — | May 27, 2026 |
| REED-KLAGES DEBRA LDirector | Grant | 1.3k | — | — | May 27, 2026 |
| FRANK JOHN BDirector | Grant | 1.3k | — | — | May 27, 2026 |
| UMPLEBY DONALD JAMES IIIDirector | Grant | 1.3k | — | — | May 27, 2026 |
No analyst notes on CVX yet.
Analyst Ratings
24 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 6 | 14 | 4 | 1 | 0 | Buy2.00 |
| 1 mo ago | 6 | 14 | 4 | 1 | 0 | Buy2.00 |
| 2 mo ago | 6 | 14 | 4 | 1 | 0 | Buy2.00 |
| 3 mo ago | 5 | 13 | 5 | 1 | 0 | Buy2.08 |